ArticleESMO open2025

Results of a patient-level pooled analysis of three studies of trastuzumab deruxtecan in HER2-positive breast cancer with active brain metastasis.

R Bartsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.